Dynavax Technologies (DVAX)

$10.89 -0.07 (-0.64%)
Market Cap 1.28B
Revenue (ttm) 277.25M
Net Income (ttm) 27.31M
EPS (ttm) N/A
PE Ratio 37.79
Forward PE N/A
Profit Margin 9.85%
Debt to Equity Ratio 0.08
Volume 1,075,600
Avg Vol 1,569,848
Day's Range N/A - N/A
Shares Out 117.43M
Stochastic %K 27%
Beta 0.89
Analysts Sell
Price Target $21.00

Company Profile

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccin...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 510 848 5100
Fax: 510 848 1327
Address:
2100 Powell Street, Suite 720, EmeryVille, United States
AStrokeOfLuck
AStrokeOfLuck Dec. 6 at 1:50 AM
$MRK $GSK $SPY $DVAX
2 · Reply
amessagefromtheodd
amessagefromtheodd Dec. 5 at 10:48 PM
$SLS $OSTX If you guys would just follow the winning formula [ You Guys 👉🏿 ] $VXRT $DVAX I mean what else do you need because it has come so natural. Friday Vibes. Live Regal!!!
0 · Reply
Offshoresurveyor
Offshoresurveyor Dec. 5 at 10:16 PM
$DVAX Crazy RFK
1 · Reply
KWalzz
KWalzz Dec. 5 at 6:32 PM
$DVAX We are used to empty promises (dialysis refile until eoy) from the so-called decision-makers. But the biggest joke this year was the so-called deal with VXRT-nobody. This was like a minor subplot in a Scorsese film with dirty little crooks who just want to distract attention. That's just a hypothesis, and I respect Scorsese's work, but at least he worked hard which I can not say about lazy mngmnt.
1 · Reply
KWalzz
KWalzz Dec. 5 at 6:20 PM
$DVAX The whole year was a complete waste of time it seems.
1 · Reply
Biogenicity
Biogenicity Dec. 5 at 5:25 PM
$DVAX No more baby Hep-B jabs will lead to more adult Heplasav-B jabs. Thanks retarded FDA!
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 5 at 3:49 PM
$MRK $GSK $DVAX
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 4 at 10:43 PM
$GSK $MRK $DVAX Some clarity on what is being voted on will certainly help
0 · Reply
LUCKY_Cool_Cat
LUCKY_Cool_Cat Dec. 4 at 4:14 PM
$DVAX If ACIP recommends no Hep-B vaccine for newborns: 1. Newborn vaccination = 0% market share → The entire newborn Hep-B market disappears. 2. Big losers: Merck & GSK → They supply most newborn doses. 3. Smallest loser: Dynavax → DVAX barely participates in newborn dosing today. 4. Possible long-term winner: Dynavax → More adult vaccinations would favor Heplisav-B.
1 · Reply
KWalzz
KWalzz Dec. 4 at 3:16 PM
$DVAX the only one important thing atm is DIALYSIS FAIL and refiling news!
0 · Reply
Latest News on DVAX
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference

Nov 19, 2025, 4:01 PM EST - 18 days ago

Dynavax to Participate at the 8th Annual Evercore Healthcare Conference

Dynavax Technologies Corporation (DVAX) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 10:31 PM EST - 4 weeks ago

Dynavax Technologies Corporation (DVAX) Q3 2025 Earnings Call Transcript

Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program

Nov 5, 2025, 4:01 PM EST - 4 weeks ago

Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program

VXRT

Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program

Nov 5, 2025, 4:00 PM EST - 4 weeks ago

Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program

VXRT

Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025

Oct 22, 2025, 4:01 PM EDT - 6 weeks ago

Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial

Oct 21, 2025, 4:01 PM EDT - 6 weeks ago

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial

3 Of My Favorite Biotech Stocks Under $10

Sep 29, 2025, 1:15 PM EDT - 2 months ago

3 Of My Favorite Biotech Stocks Under $10

FOLD MRNA NUVB PFE

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

Aug 27, 2025, 4:05 PM EDT - 3 months ago

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

Dynavax's shingles vaccine shows similar immune response to GSK's shot in study

Aug 21, 2025, 8:22 AM EDT - 3 months ago

Dynavax's shingles vaccine shows similar immune response to GSK's shot in study

GSK

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

Aug 21, 2025, 8:00 AM EDT - 3 months ago

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

Dynavax Technologies: A Dip To Accumulate

Aug 11, 2025, 8:41 AM EDT - 4 months ago

Dynavax Technologies: A Dip To Accumulate

Dynavax Technologies Corporation (DVAX) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 10:51 PM EDT - 4 months ago

Dynavax Technologies Corporation (DVAX) Q2 2025 Earnings Call Transcript

Dynavax (DVAX) Q2 Revenue Jumps 29%

Aug 7, 2025, 5:25 PM EDT - 4 months ago

Dynavax (DVAX) Q2 Revenue Jumps 29%

Dynavax Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:00 PM EDT - 4 months ago

Dynavax Reports Second Quarter 2025 Financial Results

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Jul 29, 2025, 4:02 PM EDT - 4 months ago

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Dynavax elects all four of its nominees after Deep Track proxy fight

Jun 11, 2025, 12:14 PM EDT - 6 months ago

Dynavax elects all four of its nominees after Deep Track proxy fight

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Jun 11, 2025, 11:01 AM EDT - 6 months ago

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Jun 9, 2025, 8:30 AM EDT - 6 months ago

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Jun 9, 2025, 7:30 AM EDT - 6 months ago

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Dynavax Comments on Glass Lewis Recommendation

Jun 4, 2025, 4:59 PM EDT - 6 months ago

Dynavax Comments on Glass Lewis Recommendation

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Jun 4, 2025, 9:27 AM EDT - 6 months ago

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

May 28, 2025, 4:10 PM EDT - 6 months ago

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

Deep Track Capital Comments on ISS Recommendation

May 23, 2025, 6:12 PM EDT - 7 months ago

Deep Track Capital Comments on ISS Recommendation

ISS backs Dynavax directors in board fight with Deep Track Capital

May 23, 2025, 1:54 PM EDT - 7 months ago

ISS backs Dynavax directors in board fight with Deep Track Capital

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

May 23, 2025, 1:44 PM EDT - 7 months ago

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

May 21, 2025, 11:48 PM EDT - 7 months ago

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

May 15, 2025, 4:00 PM EDT - 7 months ago

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

May 12, 2025, 7:30 AM EDT - 7 months ago

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

May 7, 2025, 4:45 PM EDT - 7 months ago

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:34 PM EDT - 7 months ago

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

May 6, 2025, 4:01 PM EDT - 7 months ago

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

May 6, 2025, 8:00 AM EDT - 7 months ago

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

May 1, 2025, 8:00 AM EDT - 7 months ago

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Apr 29, 2025, 7:30 AM EDT - 7 months ago

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Apr 22, 2025, 4:00 PM EDT - 8 months ago

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Apr 21, 2025, 4:05 PM EDT - 8 months ago

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Apr 17, 2025, 7:15 AM EDT - 8 months ago

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Apr 16, 2025, 8:00 AM EDT - 8 months ago

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Dynavax Files Preliminary Proxy Statement

Apr 3, 2025, 5:40 PM EDT - 8 months ago

Dynavax Files Preliminary Proxy Statement

Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors

Mar 10, 2025, 8:00 AM EDT - 9 months ago

Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors

Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase

Mar 6, 2025, 6:00 AM EST - 9 months ago

Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share

Mar 3, 2025, 5:58 PM EST - 9 months ago

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share

Dynavax to Participate in Upcoming Investor Conferences

Feb 25, 2025, 4:10 PM EST - 10 months ago

Dynavax to Participate in Upcoming Investor Conferences

Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 6:38 PM EST - 10 months ago

Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript

Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance

Feb 20, 2025, 4:01 PM EST - 10 months ago

Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

Feb 19, 2025, 4:52 PM EST - 10 months ago

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting

Feb 19, 2025, 9:00 AM EST - 10 months ago

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting

Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors

Feb 19, 2025, 8:04 AM EST - 10 months ago

Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Feb 11, 2025, 3:11 PM EST - 10 months ago

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

Feb 6, 2025, 5:42 PM EST - 10 months ago

Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

AStrokeOfLuck
AStrokeOfLuck Dec. 6 at 1:50 AM
$MRK $GSK $SPY $DVAX
2 · Reply
amessagefromtheodd
amessagefromtheodd Dec. 5 at 10:48 PM
$SLS $OSTX If you guys would just follow the winning formula [ You Guys 👉🏿 ] $VXRT $DVAX I mean what else do you need because it has come so natural. Friday Vibes. Live Regal!!!
0 · Reply
Offshoresurveyor
Offshoresurveyor Dec. 5 at 10:16 PM
$DVAX Crazy RFK
1 · Reply
KWalzz
KWalzz Dec. 5 at 6:32 PM
$DVAX We are used to empty promises (dialysis refile until eoy) from the so-called decision-makers. But the biggest joke this year was the so-called deal with VXRT-nobody. This was like a minor subplot in a Scorsese film with dirty little crooks who just want to distract attention. That's just a hypothesis, and I respect Scorsese's work, but at least he worked hard which I can not say about lazy mngmnt.
1 · Reply
KWalzz
KWalzz Dec. 5 at 6:20 PM
$DVAX The whole year was a complete waste of time it seems.
1 · Reply
Biogenicity
Biogenicity Dec. 5 at 5:25 PM
$DVAX No more baby Hep-B jabs will lead to more adult Heplasav-B jabs. Thanks retarded FDA!
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 5 at 3:49 PM
$MRK $GSK $DVAX
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 4 at 10:43 PM
$GSK $MRK $DVAX Some clarity on what is being voted on will certainly help
0 · Reply
LUCKY_Cool_Cat
LUCKY_Cool_Cat Dec. 4 at 4:14 PM
$DVAX If ACIP recommends no Hep-B vaccine for newborns: 1. Newborn vaccination = 0% market share → The entire newborn Hep-B market disappears. 2. Big losers: Merck & GSK → They supply most newborn doses. 3. Smallest loser: Dynavax → DVAX barely participates in newborn dosing today. 4. Possible long-term winner: Dynavax → More adult vaccinations would favor Heplisav-B.
1 · Reply
KWalzz
KWalzz Dec. 4 at 3:16 PM
$DVAX the only one important thing atm is DIALYSIS FAIL and refiling news!
0 · Reply
KWalzz
KWalzz Dec. 4 at 3:13 PM
$DVAX is becoming the synonym for the most ridiculous idiot pumper stock ... I wish ST had a mass blocking feature. this all is only about distraction from the countless management fails ...
1 · Reply
Dilly_Due
Dilly_Due Dec. 4 at 2:53 PM
$VXRT $DVAX Any in the DVAX community care to take a guess at #4? https://stocktwits.com/doubleyou2/message/638139209
0 · Reply
triniblockchain
triniblockchain Dec. 3 at 5:01 AM
$DVAX hold this for 6-7 years are we ever gonna get to $50? Sincere question
4 · Reply
KWalzz
KWalzz Dec. 2 at 8:48 PM
$DVAX ??? not even in the remotest remote is dvax about newborn hepb shots ... and it will never be .. with its loser management ...
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 2 at 8:01 PM
$GSK $MRK $DVAX
1 · Reply
Frigg
Frigg Dec. 2 at 7:06 PM
$DVAX Fireside chat starting soon. https://investors.dynavax.com/news-releases/news-release-details/dynavax-participate-8th-annual-evercore-healthcare-conference
2 · Reply
KWalzz
KWalzz Dec. 2 at 6:00 PM
$DVAX 12/02 STILL NO NEWS from the laziest and most incompetent management team in bio world in 2025 ...
0 · Reply
faze2
faze2 Dec. 2 at 4:18 PM
$DVAX DVAX is buying back its stock. Would not DVAX want to but the stock as cheaply as possible? Would not a lower DVAX stock price benefit DVAX by allowing DVAX's buy-back to become less expensive? Why would DVAX, during its buy-back, want its stock price to rise? I wonder; does DVAX's stock buy-back create a conflict of interest with existing shareholders?
1 · Reply
HeadlessHorsemen
HeadlessHorsemen Dec. 2 at 2:59 PM
$DVAX Another desultory day in the offing with DVAX.
0 · Reply
RunnerSignals
RunnerSignals Dec. 2 at 4:45 AM
$UNF $DTE $DVAX $OSW $ASTS Slipping, crossing lines, flirting with oversold Perfect setup for either panic...or a sneaky bounce https://stocksrunner.com/news/2025-12-01-daily-market-pulse-advanced-technical-analysis
0 · Reply
chrlaff01
chrlaff01 Dec. 1 at 3:21 PM
$DVAX $11 range too scary to stay in?
0 · Reply
KWalzz
KWalzz Nov. 28 at 2:30 PM
$DVAX CFO on Mar 4: "So we do expect to refile (DIALYSIS FAIL) by the END OF THE YEAR ...". Did he mean 2025? WHERE IS THE UPDATE ?
2 · Reply